Investing Ideas
/
U.S. Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

U.S. Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.

19 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
CLNN Clene	US$4.74	1.3%	-52.0%	US$37.7m	US$45.17	PS89.8x	E59.1%	n/a
SPRY ARS Pharmaceuticals	US$14.32	5.7%	130.6%	US$1.4b	US$27.25	PS541.9x	E58.7%	n/a
CORT Corcept Therapeutics	US$61.53	4.2%	191.6%	US$6.4b	US$75.25	PE45.9x	E35.4%	n/a
OSTX OS Therapies	US$2.60	-14.2%	n/a	US$55.2m	US$14.67	PE-7.4x	E23.8%	n/a
BFRI Biofrontera	US$1.05	2.9%	-21.1%	US$8.2m	US$11.50	PS0.2x	E61.3%	n/a
PRPH ProPhase Labs	US$0.45	-12.3%	-90.8%	US$11.0m	US$21.00	PS0.8x	E77.4%	0%
NRXP NRx Pharmaceuticals	US$3.14	7.2%	-16.0%	US$37.9m	US$31.67	PE-1.9x	E58.8%	n/a
BRTX BioRestorative Therapies	US$2.35	1.5%	44.2%	US$16.2m	US$13.00	PS43.1x	E64.3%	n/a
TLSI TriSalus Life Sciences	US$4.89	-0.2%	-45.9%	US$151.6m	US$11.64	PS5.5x	E60.7%	n/a
LQDA Liquidia	US$14.26	2.2%	11.6%	US$1.2b	US$25.00	PS77.3x	E57.2%	n/a
KRYS Krystal Biotech	US$156.30	1.9%	40.5%	US$4.6b	US$206.25	PE85.8x	E36.7%	n/a
PLX Protalix BioTherapeutics	US$2.37	0%	63.4%	US$170.1m	US$14.00	PS3.8x	E118.3%	n/a
FENC Fennec Pharmaceuticals	US$6.47	12.9%	-35.2%	US$178.6m	US$12.60	PS3.6x	E48.6%	n/a
EVAX Evaxion Biotech	US$3.39	42.4%	-82.7%	US$5.1m	US$41.58	PS1.2x	E48.8%	n/a
HROW Harrow	US$32.35	-6.4%	239.5%	US$1.2b	US$59.85	PS6.8x	E85.3%	n/a
CDXC ChromaDex	US$5.90	-0.3%	304.1%	US$447.8m	US$7.96	PE304.1x	E81.8%	n/a
IPA ImmunoPrecise Antibodies	US$0.46	-28.6%	-74.6%	US$17.5m	US$5.00	PS0.9x	E75.1%	n/a
CSBR Champions Oncology	US$11.09	3.5%	90.9%	US$147.0m	US$8.00	PS2.8x	E101.4%	n/a
BTMD biote	US$5.68	0.5%	49.9%	US$208.6m	US$9.87	PE24.6x	E69.0%	n/a

Page 1 of 1